EVALUATION OF SERUM TESTOSTERONE, ESTRADIOL AND PSA LEVELS AMONG PRE- AND POST-MENOPAUSE BREAST CANCER FEMALE PATIENTS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2018, Vol 7, Issue 2
Abstract
Breast cancer has emerged as the most common malignancy among females during the last few years. In Egypt breast cancer accounts for 37.7% of all new cancer cases among women. Early diagnosis is essential for disease management so research is underway to identify potential serological bio markers. Objective: To identify the diagnostic role of total prostate-specific antigen, CA 15-3, testosterone and estradiol levels in breast cancer in women pre and post-surgery. Also, studying the possible effect of diabetes mellitus in breast cancer female patients pre and post-menopause on levels of PSA and other parameters. Methods: The current study included 124 female patients with breast cancer and 37 healthy women serving as normal control groups. Serum CA 15-3, PSA, testosterone and estradiol levels were assayed before surgery and three week after surgery and in healthy controls. Results: In present study there was very highly significant increase in serum CA 15-3, PSA, estradiol and testosterone levels in all patients group compared to the control. On comparing Pre-surgery patients group to the Post-surgery patients group, it was found that serum CA 15-3, PSA and testosterone levels fall following breast surgery. Concerning diabetic patients, serum CA 15-3, PSA and testosterone levels were non-significantly changed compared to non-diabetic patients in all groups. As evident from the present data, diabetic female patients had lower estradiol level than non-diabetic female patients. Conclusions: The present study indicated a clinical significance of measurement of serum PSA in the diagnosis of women with breast cancer, and may be a useful marker for monitoring the response to treatment. CA15-3 is an important diagnostic, prognostic indicator. Estradiol and testosterone levels may play important roles in the development of breast cancer in older women. A single measurement of bioavailable estradiol and testosterone may be used to estimate a woman's risk for breast cancer. Based on these data we conclude that serum CA15-3 and PSA levels are useful tumor markers for breast cancer patient diagnosis or monitoring.
Authors and Affiliations
Dr. Abdel-Aziz A. F.
Keywords
Related Articles
- EP ID EP620619
- DOI -
- Views 149
- Downloads 0
ANTIOXIDANTS EFFECTS IN CANCER SURVIVORS: A SHORT PERSPECTIVE
There have been intense debates on the use of antioxidants as neoadjuvant therapy or in combination with anti-cancer agents in the treatment of human malignancies. While the safety and effectiveness of commonly used diet...
INHIBITORY ACTIVITY OF CHALCONE MOETIES ON PANCREATIC LIPASE ENZYME: A REVIEW
The main challenge of today’s research is to design a novel drug for the treatment of ailments with lesser side effects. Obesity derives from Latin word obesities which means tout, fat, or plump. Medically, obesity is a...
SYNTHESIS, CHARACTERIZATION, AND ANTI-BACTERIAL ASSESSMENT OF NEW GATIFLOXACIN ANALOGUES
New gatifloxacin analogues were synthesized by coupling with different sulfonamide derivatives (sulfanilamide, and sulfacetamide), using chloroacetyl chloride linker, in order to increase the bulkiness at position 7 of t...
CYTOTOXIC AND WOUND HEALING POTENTIAL OF DMSO EXTRACTS OF PROPOLIS IN MDA-MB-231 CELLS
The aim of this study was to evaluate cytotoxic and wound healing effects of dimethyl sulfoxide (DMSO) extracts of Turkish propolis in MDA-MB-231 cancer cells. For the study of cytotoxic and wound healing effects of prop...
USE OF SOFTWARE AND COMPUTER PROGRAMS IN PHARMACOLOGY AND DRUG DISCOVERY RESEARCH: PREDICTION OF PHYSICAL, CHEMICAL AND PHARMACOLOGICAL PROPERTIES IN SILICO
The in silico approaches in pharmacological research have revolutionized the research in drug discovery and are successfully functional in reducing the time, intellect and money in the drug discovery pipeline. Bringing t...